Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups.
暂无分享,去创建一个
D R Shapiro | E Seeman | D B Karpf | K E Ensrud | C C Johnston | S Adami | S T Harris | A C Santora | L J Hirsch | L Oppenheimer | D Thompson
[1] P. Ridker,et al. Discordance between Meta-analyses and Large-Scale Randomized, Controlled Trials: Examples from the Management of Acute Myocardial Infarction , 1995, Annals of Internal Medicine.
[2] G. Spears,et al. Treatment of postmenopausal osteoporosis with calcitriol or calcium , 1992 .
[3] S Phillips,et al. The direct medical costs of osteoporosis for American women aged 45 and older, 1986. , 1988, Bone.
[4] M. A. Hansen,et al. Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. , 1992, BMJ.
[6] L. Bouter,et al. Vitamin D Supplementation and Fracture Incidence in Elderly Persons , 1996, Annals of Internal Medicine.
[7] P. Delmas,et al. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. , 1994, The Journal of clinical endocrinology and metabolism.
[8] A. Lane,et al. Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen , 1992, Annals of Internal Medicine.
[9] William M. O'Fallon,et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. , 1990 .
[10] S. Ortolani,et al. Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis. , 1995, Bone.
[11] L. Melton,et al. The prevention and treatment of osteoporosis. , 1992, The New England journal of medicine.
[12] S. Cummings,et al. Which Fractures Are Associated with Low Appendicular Bone Mass in Elderly Women , 1991 .
[13] S. Cummings,et al. The accuracy of self-report of fractures in elderly women: evidence from a prospective study. , 1992, American journal of epidemiology.
[14] R B Wallace,et al. A model of lifetime osteoporosis impact. , 1991, Archives of internal medicine.
[15] S. Cummings,et al. Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women. , 1989, Archives of internal medicine.
[16] G. Rodan,et al. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. , 1991, The Journal of clinical investigation.
[17] François Duboeuf,et al. Vitamin D3 and Calcium to Prevent Hip Fractures in Elderly Women , 1992 .
[18] H. Genant,et al. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. , 1990, The New England journal of medicine.
[19] S. Cummings,et al. The future of hip fractures in the United States. Numbers, costs, and potential effects of postmenopausal estrogen. , 1990, Clinical orthopaedics and related research.
[20] W. O'Fallon,et al. Long‐term fracture prediction by bone mineral assessed at different skeletal sites , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[21] J. Kanis,et al. Perspective : The diagnosis of osteoporosis , 1994 .
[22] H. Genant,et al. Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling. , 1995, The American journal of medicine.
[23] S. Cummings,et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.
[24] W. Mysiw,et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. , 1990, The New England journal of medicine.
[25] J Dequeker,et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. , 1995, The New England journal of medicine.
[26] B. Adams-Huet,et al. Treatment of Postmenopausal Osteoporosis with Slow-Release Sodium Fluoride: Final Report of a Randomized Controlled Trial , 1995, Annals of Internal Medicine.